Technical Analysis for GKOS - Glaukos Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 119.82 | 1.84% | 2.17 |
Earnings due: Jul 31
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Three Weeks Tight | Range Contraction | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Fell Below 20 DMA | Bearish | 1.84% | |
| Multiple of Ten Bearish | Other | 1.84% | |
| Calm After Storm | Range Contraction | -2.27% | |
| Inside Day | Range Contraction | -2.27% |
| Alert | Time |
|---|---|
| Up 2% | about 13 hours ago |
| Possible NR7 | about 13 hours ago |
| Possible Inside Day | about 13 hours ago |
| 60 Minute Opening Range Breakout | about 16 hours ago |
| Gap Up Closed | about 17 hours ago |
Get a Trading Assistant
- Earnings date: 07/31/2024
Glaukos Corporation Description
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmology Ophthalmic Drainage Glaucoma Vision Implant Blindness Incision Treatment Of Glaucoma Eye Surgery Cornea Intraocular Pressure
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 126.96 |
| 52 Week Low | 59.22 |
| Average Volume | 514,359 |
| 200-Day Moving Average | 91.58 |
| 50-Day Moving Average | 115.69 |
| 20-Day Moving Average | 121.26 |
| 10-Day Moving Average | 122.06 |
| Average True Range | 4.01 |
| RSI (14) | 50.98 |
| ADX | 22.68 |
| +DI | 22.54 |
| -DI | 26.54 |
| Chandelier Exit (Long, 3 ATRs) | 114.94 |
| Chandelier Exit (Short, 3 ATRs) | 124.44 |
| Upper Bollinger Bands | 126.02 |
| Lower Bollinger Band | 116.49 |
| Percent B (%b) | 0.35 |
| BandWidth | 7.86 |
| MACD Line | 1.70 |
| MACD Signal Line | 2.39 |
| MACD Histogram | -0.6896 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 123.87 | ||||
| Resistance 3 (R3) | 123.53 | 121.84 | 123.20 | ||
| Resistance 2 (R2) | 121.84 | 120.81 | 122.01 | 122.97 | |
| Resistance 1 (R1) | 120.83 | 120.17 | 121.34 | 121.17 | 122.74 |
| Pivot Point | 119.14 | 119.14 | 119.39 | 119.31 | 119.14 |
| Support 1 (S1) | 118.13 | 118.11 | 118.64 | 118.47 | 116.90 |
| Support 2 (S2) | 116.44 | 117.47 | 116.61 | 116.67 | |
| Support 3 (S3) | 115.43 | 116.44 | 116.45 | ||
| Support 4 (S4) | 115.77 |
